HIV R4P no date logo

Home Banner r081516



Committees

The challenge of developing a rich, balanced, and cutting-edge program for HIVR4P 2016 rests with the 46-member Program Organizing Committee (POC). This diverse, multi-disciplinary advisory committee of experts from around the world represents all areas of biomedical prevention research and advocacy. The POC works closely with the Co-Chairs to develop a balanced and representative program. 

POC members identify the most pressing topics and most qualified speakers in the field to be part of the R4P program. We salute the HIVR4P Program Organizing Committee for their tireless and voluntary efforts to build a diverse and engaging conference program.

Program Organizing Committee Members

Marcus Altfeld
Heinrich-Pette-Institute, Leibniz-Institute for Experimental Virology, Germany

Jintanat Ananworanich
US Military HIV Research Program, United States

Dan Barouch
Beth Israel Deaconess Medical Center, Ragon Institute of MGH MIT and Harvard, United States

Gina Brown
Office of AIDS Research, National Institutes of Health, United States

Susan Buchbinder
San Francisco Department of Public Health, United States

Elizabeth Bukusi
Kenya Medical Research Institute, Kenya

Kundai Chinyenze
International AIDS Vaccine Initiative, Kenya

Z. Mike Chirenje
University of Zimbabwe-University of California San Francisco Collaborative Research Program, Zimbabwe

Myron Cohen
University of North Carolina, United States

David Cooper
Kirby Institute, University of New South Wales, Australia

Carl Dieffenbach
National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States

Mark Feinberg
International AIDS Vaccine Initiative, United States

Geoff Garnett
Bill & Melinda Gates Foundation, United States

Barney Graham
National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States

Beatriz Grinsztejn
Oswaldo Cruz Foundation, Brazil

Scott Hammer
Columbia University, United States

Catherine Hankins
Amsterdam Institute for Global Health and Development, Netherlands

Barton Haynes
Duke University, United States

Sharon Hillier
University of Pittsburgh – School of Medicine, United States

Eric Hunter
Emory University and Emory Vaccine Center, United States

Anatoli Kamali
MRC/UVRI Uganda Virus Research Unit, Uganda

Angela Kashuba
University of North Carolina, United States

Milly Katana
Microbicides Trial Network, Uganda

Wayne Koff
Human Vaccines Project, United States

Raphael Landovitz
UCLA Center for Clinical AIDS Research and Education, United States

Jean-Daniel Lelievre
INSERM/VRI (University Paris-Est Creteil), France

Bonnie Mathieson
Office of AIDS Research, National Institutes of Health, United States

Ken Mayer
The Fenway Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, United States

Sheena McCormack
MRC Clinical Trials Unit at UCL, United Kingdom

Lyle McKinnon
University of Manitoba / Centre for the AIDS Programme of Research in South Africa, Canada and South Africa

Andrew Mujugira
Department of Global Health, University of Washington, Uganda

Thumbi Ndung'u
University of KwaZulu-Natal, South Africa

Jim Pickett
International Rectal Microbicide Advocates, United States

Gita Ramjee
HIV Prevention Research Unit, South African Medical Research Council, South Africa

Helen Rees
RHI: Wits Reproductive Health and HIV Institute, South Africa

Nina Russell
Bill & Melinda Gates Foundation, United States

William Schief
Scripps and International AIDS Vaccine Initiative, United States

Barbara Shacklett
University of California at Davis, United States

Yiming Shao
National Center for AIDS/STD Control and Prevention (NCAIDS), Department of the Research on Virology and Immunology, and Chinese Center for Disease Control and Prevention, China

Robin Shattock
Imperial College, United Kingdom

William Snow
Global HIV Vaccine Enterprise, United States

Morenike Ukpong
Obafemi Awolowo University, Nigeria

Mitchell Warren
AVAC, United States

Kim Woodrow
University of Washington, United States

Ntando Yola
Desmond Tutu HIV Foundation, South Africa

 

 

In addition to the Program Organizing Committee, HIV R4P would like to thank the following individuals for reviewing abstracts.

Abstract Review Committee Members

Alash'le Abimiku
Institute of Human Virology Nigeria, Nigeria

Todd Allen
Harvard University, United States

Galit Alter
Ragon Institute, United States

Rama Amara
Emory University, United States

Jared Baeten
University of Washington, United States

Prince Bahati
International AIDS Vaccine Initiative, Kenya

Christian Brander
Irsicaixa, Spain

Nomita Chandhiok
Indian Council of Medical Research, India

Robert Chen
Centers for Disease Control and Prevention, United States

Josephine Cox
International AIDS Vaccine Initiative, United States

Cynthia Derdeyn
Emory University, United States

Gustavo Doncel
Eastern Virginia Medical School, United States

Daniel Douek
Vaccine Research Center, National Institutes of Health, United States

Patricia Fast
International AIDS Vaccine Initiative, United States

Kevin Fisher
AVAC, United States

Keith Fowke
University of Manitoba, Canada

Nicole Frahm
Fred Hutchinson Cancer Research Center, United States

Henry Gabelnick
Eastern Virginia Medical School Emeritus, United States

J. Victor Garcia
University of North Carolina at Chapel Hill, United States

Paul Goepfert
University of Alabama at Birmingham, United States

Tomas Hanke
University of Oxford, United Kingdom

Craig Hendrix
John Hopkins University, United States

Walid Heneine
Centers for Disease Control and Prevention, United States

Betsy Herold
Albert Einstein College of Medicine, United States

Stephen Kent
University of Melbourne, Australia

Jerome Kim
International Vaccine Institute, South Korea

Charles Lacey
University of York, United Kingdom

Roger Le Grand
CEA, France

Yves Levy
INSERM/VRI, France

George Lewis
Institute of Human Virology, United States

Amapola Manrique
Global HIV Vaccine Enterprise, United States

John Mascola
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States

Benoit Masse
University of Montreal, Canada

Barbara Mensch
Population Council, United States

Nelson Michael
US Military HIV Research Program, United States

Penny Moore
University of the Witwatersrand, South Africa

Jeremy Nuttall
International Partnership for Microbicides, United States

Jean Patterson
Office of AIDS Research, United States

Dorothy Patton
University of Washington, United States

Punnee Pitisuttithum
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Thailand

Damian Purcell
University of Melbourne, Australia

Merlin Robb
US Military HIV Research Program, United States

Harriet Robinson
GeoVax Inc., United States

Lisa Rohan
University of Pittsburgh, United States

Morgane Rolland
US Military HIV Research Program, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., United States

Joseph Romano
NWJ Group, United States

Ruth Ruprecht
Texas Biomed, United States

Jeffrey Safrit
International AIDS Vaccine Initiative, United States

Eric Sandström
Karolinska Institutet, Sweden

Gabriella Scarlatti
Global HIV Vaccine Enterprise, United States

Alexandra Schuetz
US Army Medical Component of the Armed Forces Research Institute of the Medical Sciences, Thailand

Olivier Schwartz
Institut Pasteur, France

Guido Silvestri
Emory University, United States

Jonathan Stadler
Witwatersrand University, South Africa

Hendrik Streeck
Institute for HIV Research, Germany

Alan Stone
MEDSA Ltd, United Kingdom

Jim Tartaglia
Sanofi Pasteur, United States

Bargavi Thyagarajan
Global HIV Vaccine Enterprise, United States

Caroline Tiemessen
National Institute for Communicable Diseases, South Africa

Georgia Tomaras
Duke Human Vaccine Institute, United States

Alexandra Trkola
University of Zurich, Switzerland

Jim Turpin
Prevention Sciences Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States

Lut Van Damme
Bill & Melinda Gates Foundation, United States

Ronald Veazey
Tulane National Primate Research Center, United States

Steven Wakefield
HIV Vaccine Trials Network, United States

Anna-Lise Williamson
University of Cape Town, South Africa

Allen Zhiwei Wu
Nanjing University Medical School, China

Susan Zolla-Pazner
Icahn Medical School at Mount Sinai, United States

 

Conference Secretariat

Governance: Global HIV Vaccine Enterprise, United States

Kristin Morrell
Funders Relations Officer

Gabriella Scarlatti
Science Director

Bargavi Thyagarajan
Science Officer

Mark Aurigemma
Media Consultant

Logistics: Conference Solutions, United States

Kate Porter
President

Hotel conference details 022416